Related references
Note: Only part of the references are listed.Circulating serum microRNAs including senescent miR-31-5p are associated with incident fragility fractures in older postmenopausal women with type 2 diabetes mellitus
Ursula Heilmeier et al.
BONE (2022)
RANKL biology
Noriko Takegahara et al.
BONE (2022)
Osteocalcin and Risks of Incident Diabetes and Diabetic Kidney Disease: A 4.6-Year Prospective Cohort Study
Xiaoqi Ye et al.
DIABETES CARE (2022)
The Role of Bone-Derived Hormones in Glucose Metabolism, Diabetic Kidney Disease, and Cardiovascular Disorders
Yuichi Takashi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
FSH may mediate the association between HbA1c and bone turnover markers in postmenopausal women with type 2 diabetes
Ke-xi Zha et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2022)
Impaired Bone Fracture Healing in Type 2 Diabetes Is Caused by Defective Functions of Skeletal Progenitor Cells
Florence Figeac et al.
STEM CELLS (2022)
Trabecular bone score and 25-hydroxyvitamin D levels in microvascular complications of type 2 diabetes mellitus
Meryam Maamar el Asri et al.
MEDICINA CLINICA (2022)
Youth-onset type 2 diabetes in Israel: A national cohort
Nehama Zuckerman Levin et al.
PEDIATRIC DIABETES (2022)
Bone fragility in diabetes: novel concepts and clinical implications
Lorenz C. Hofbauer et al.
LANCET DIABETES & ENDOCRINOLOGY (2022)
Thyroid and bone turnover markers in type 2 diabetes: results from the METAL study
Yi Chen et al.
ENDOCRINE CONNECTIONS (2022)
The roles of osteoprotegerin in cancer, far beyond a bone player
Yufei Wang et al.
CELL DEATH DISCOVERY (2022)
Increased Cortical Porosity, Reduced Cortical Thickness, and Reduced Trabecular and Cortical Microhardness of the Superolateral Femoral Neck Confer the Increased Hip Fracture Risk in Individuals with Type 2 Diabetes
Aleksandar Cirovic et al.
CALCIFIED TISSUE INTERNATIONAL (2022)
Osteocalcin and Risks of Incident Diabetes and Diabetic Kidney Disease: A 4.6-Year Prospective Cohort Study
Xiaoqi Ye et al.
DIABETES CARE (2022)
Country-Specific Prevalence and Incidence of Youth-Onset Type 2 Diabetes: A Narrative Literature Review
Jane L. Lynch et al.
ANNALS OF NUTRITION AND METABOLISM (2021)
Glucose variability and low bone turnover in people with type 2 diabetes
Jakob Starup-Linde et al.
BONE (2021)
mTOR inhibition improves mitochondria function/biogenesis and delays cardiovascular aging in kidney transplant recipients with chronic graft dysfunction
Barbara Infante et al.
Aging-US (2021)
Emerging biomarkers of delayed graft function in kidney transplantation
Valeria Mezzolla et al.
TRANSPLANTATION REVIEWS (2021)
Association Between Factors Involved in Bone Remodeling (Osteoactivin and OPG) With Plasma Levels of Irisin and Meteorin-Like Protein in People With T2D and Obesity
Preethi Cherian et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Diabetes and Bone Fragility
Camila Romero-Diaz et al.
DIABETES THERAPY (2021)
Sclerostin: a new biomarker of CKD-MBD
Andreja Figurek et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2020)
Discovery, development, and future application of senolytics: theories and predictions
Erin O. Wissler Gerdes et al.
FEBS JOURNAL (2020)
FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease
Ana Luisa Ribeiro et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2020)
Association of Glycated Proteins with Inflammatory Proteins and Periodontal Disease Parameters
Jeneen Panezai et al.
JOURNAL OF DIABETES RESEARCH (2020)
The role of cellular senescence in ageing and endocrine disease
Sundeep Khosla et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
Sclerostin Regulation, Microarchitecture, and Advanced Glycation End-Products in the Bone of Elderly Women With Type 2 Diabetes
Alessandra Piccoli et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Determinants of Bone Material Strength and Cortical Porosity in Patients with Type 2 Diabetes Mellitus
Parinya Samakkarnthai et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Accelerated osteocyte senescence and skeletal fragility in mice with type 2 diabetes
Brittany A. Eckhardt et al.
JCI INSIGHT (2020)
Re-thinking the bone remodeling cycle mechanism and the origin of bone loss
Jean-Marie Delaisse et al.
BONE (2020)
Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony
Stanley M. H. Yeung et al.
CURRENT DIABETES REPORTS (2020)
Bone Vasculature and Bone Marrow Vascular Niches in Health and Disease
Junyu Chen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Incident Type 2 Diabetes Among Individuals With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
Christopher Jepson et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Acceleration of β Cell Aging Determines Diabetes and Senolysis Improves Disease Outcomes
Cristina Aguayo-Mazzucato et al.
CELL METABOLISM (2019)
The Klotho proteins in health and disease
Makoto Kuro-o
NATURE REVIEWS NEPHROLOGY (2019)
An update on the role of RANKL-RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases
Giacomina Brunetti et al.
WORLD JOURNAL OF PEDIATRICS (2019)
Diabetes and Deficits in Cortical Bone Density, Microarchitecture, and Bone Size: Framingham HR-pQCT Study
Elizabeth J. Samelson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study
L. -C. Desbiens et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Type 2 diabetes in adolescents and young adults
Nadia Lascar et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Type 2 diabetes affects bone cells precursors and bone turnover
Francesca Sassi et al.
BMC ENDOCRINE DISORDERS (2018)
Association between resistin and fibroblast growth factor 23 in patients with type 2 diabetes mellitus
Akio Nakashima et al.
SCIENTIFIC REPORTS (2018)
Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis
Katrine Hygum et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Type 2 Diabetes Mellitus Is Associated With Better Bone Microarchitecture But Lower Bone Material Strength and Poorer Physical Function in Elderly Women: A Population-Based Study
Anna G. Nilsson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
Eugene J. Barrett et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Bone Turnover Is Suppressed in Insulin Resistance, Independent of Adiposity
Katherine T. Tonks et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Associations between FGF21, osteonectin and bone turnover markers in type 2 diabetic patients with albuminuria
Lingling Xu et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters
Markus Ketteler et al.
KIDNEY INTERNATIONAL (2017)
Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012
Elizabeth J. Mayer-Davis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes
Peng Duan et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2017)
Bone disease in diabetes: another manifestation of microvascular disease?
Vikram V. Shanbhogue et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study
Zhou Zhou et al.
DIABETES THERAPY (2017)
Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study
Zhou Zhou et al.
DIABETES THERAPY (2017)
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Foreword
David C. Wheeler et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2017)
Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study
S. Ray et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)
Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function
G. Castellano et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Bone Microarchitecture in Men and Women with Diabetes: The Importance of Cortical Porosity
Julien Paccou et al.
CALCIFIED TISSUE INTERNATIONAL (2016)
Compromised cortical bone compartment in type 2 diabetes mellitus patients with microvascular disease
Vikram V. Shanbhogue et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Kidney Function and Fracture Risk: The Atherosclerosis Risk in Communities (ARIC) Study
Natalie R. Daya et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Influence of high glucose and advanced glycation end-products (ages) levels in human osteoblast-like cells gene expression
Cristina Miranda et al.
BMC MUSCULOSKELETAL DISORDERS (2016)
Biochemical bone turnover markers in diabetes mellitus - A systematic review
Jakob Starup-Linde et al.
BONE (2016)
Differences in biochemical bone markers by diabetes type and the impact of glucose
Jakob Starup-Linde et al.
BONE (2016)
Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014
Maryam Afkarian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes
Jessica R. Furst et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Altered serum levels of FGF-23 and magnesium are independent risk factors for an increased albumin-to-creatinine ratio in type 2 diabetics with chronic kidney disease
Ana Paula Silva et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
SPARC/osteonectin in mineralized tissue
Emilie M. Rosset et al.
MATRIX BIOLOGY (2016)
Cortical bone laminar analysis reveals increased midcortical and periosteal porosity in type 2 diabetic postmenopausal women with history of fragility fractures compared to fracture-free diabetics
U. Heilmeier et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition
S. Epstein et al.
OSTEOPOROSIS INTERNATIONAL (2016)
A Single Nucleotide Polymorphism in Osteonectin 30 Untranslated Region Regulates Bone Volume and is Targeted by miR-433
Neha S. Dole et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Type 2 diabetes alters bone and marrow blood flow and vascular control mechanisms in the ZDF rat
John N. Stabley et al.
JOURNAL OF ENDOCRINOLOGY (2015)
Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma
Margherita Gigante et al.
MEDICINE (2015)
Volumetric femoral BMD, bone geometry, and serum sclerostin levels differ between type 2 diabetic postmenopausal women with and without fragility fractures
U. Heilmeier et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Defects in cortical microarchitecture among African-American women with type 2 diabetes
E. W. Yu et al.
OSTEOPOROSIS INTERNATIONAL (2015)
In Vivo Assessment of Bone Quality in Postmenopausal Women With Type 2 Diabetes
Joshua N. Farr et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation
Jianwen Wei et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Advanced Glycation End Products Play Adverse Proinflammatory Activities in Osteoporosis
Roberta Sanguineti et al.
MEDIATORS OF INFLAMMATION (2014)
Type 2 diabetes mellitus and fracture risk
Anastasia D. Dede et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Reduced Renal α-Klotho Expression in CKD Patients and Its Effect on Renal Phosphate Handling and Vitamin D Metabolism
Hirokazu Sakan et al.
PLOS ONE (2014)
Unlocking the biology of RAGE in diabetic microvascular complications
Michaele B. Manigrasso et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
The Effect of Renal Dysfunction on Circulating Sclerostin Level in Patients with Type 2 Diabetes
Se Hwa Kim et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
CKD-Mineral and Bone Disorder Management in Kidney Transplant Recipients
Hala M. Alshayeb et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus
R. Strollo et al.
DIABETOLOGIA (2013)
Increased Cortical Porosity in Type 2 Diabetic Postmenopausal Women With Fragility Fractures
Janina M. Patsch et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Elevated Sclerostin Levels Are Associated With Vertebral Fractures in Patients With Type 2 Diabetes Mellitus
Masahiro Yamamoto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
TBS (Trabecular Bone Score) and Diabetes-Related Fracture Risk
William D. Leslie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes
Ju-Young Kim et al.
LIFE SCIENCES (2013)
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Juan Carlos Acosta et al.
NATURE CELL BIOLOGY (2013)
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus
Stefan Kiechl et al.
NATURE MEDICINE (2013)
Diabetes, Biochemical Markers of Bone Turnover, Diabetes Control, and Bone
Jakob Starup-Linde
Frontiers in Endocrinology (2013)
Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies
Lili Ma et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2012)
Sclerostin Levels Associated with Inhibition of the Wnt/β-Catenin Signaling and Reduced Bone Turnover in Type 2 Diabetes Mellitus
Agostino Gaudio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes
Luigi Gennari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Bone structure and turnover in type 2 diabetes mellitus
A. Shu et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Rapamycin-Induced Hypophosphatemia and Insulin Resistance Are Associated With mTORC2 Activation and Klotho Expression
T. Tataranni et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Three-Dimensional Cortical Bone Microstructure in a Rat Model of Hypoxia-Induced Growth Retardation
Takeshi Matsumoto et al.
CALCIFIED TISSUE INTERNATIONAL (2011)
FGF-23 as a Predictor of Renal Outcome in Diabetic Nephropathy
Silvia M. Titan et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Serum insulin-like growth factor-I is a marker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus
I. Kanazawa et al.
OSTEOPOROSIS INTERNATIONAL (2011)
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
Jean -Philippe Coppe et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
High-Resolution Peripheral Quantitative Computed Tomographic Imaging of Cortical and Trabecular Bone Microarchitecture in Patients with Type 2 Diabetes Mellitus
Andrew J. Burghardt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states
Bernardo Nuche-Berenguer et al.
REGULATORY PEPTIDES (2010)
The relationship between adipokines, osteocalcin and bone quality in chronic kidney disease
Justine Bacchetta et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Pentosidine effects on human osteoblasts in vitro
Roberta Sanguineti et al.
MAILLARD REACTION: RECENT ADVANCES IN FOOD AND BIOMEDICAL SCIENCES (2008)
High D(+)glucose concentration inhibits RANKL-induced osteoclastogenesis
Y. Wittrant et al.
BONE (2008)
Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM 17
Ci-Di Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Endocrine regulation of energy metabolism by the skeleton
Na Kyung Lee et al.
CELL (2007)
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction
Paola Secchiero et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study
M. Jadoul et al.
KIDNEY INTERNATIONAL (2006)
Risk of fracture in women with type 2 diabetes: The Women's Health Initiative Observational Study
Denise E. Bonds et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture
M. Saito et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Characterization of insulin secretion and resistance in type 2 diabetes of adolescents
C Druet et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Diabetes and advanced glycoxidation end products
Amy G. Huebschmann et al.
DIABETES CARE (2006)
Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links
CJ Hernandez et al.
BONE (2005)
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues
KM Thrailkill et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone
S Kume et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation
KES Poole et al.
FASEB JOURNAL (2005)
Youth type 2 diabetes -: Insulin resistance, β-cell failure, or both?
N Gungor et al.
DIABETES CARE (2005)
Advanced glycation endproducts - role in pathology of diabetic complications
N Ahmed
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix
AD McCarthy et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Reversal of human cellular senescence:: roles of the p53 and p16 pathways
CM Beauséjour et al.
EMBO JOURNAL (2003)
Infrared analysis of the mineral and matrix in bones of osteonectin-null mice and their wildtype controls
AL Boskey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Risk of hip and renal fracture among dialysis transplant recipients
AM Ball et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development
AD McCarthy et al.
ACTA DIABETOLOGICA (2001)
Advanced glycation end-products: a review
R Singh et al.
DIABETOLOGIA (2001)
Osteopenia and decreased bone formation in osteonectin-deficient mice
AM Delany et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
